| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Renalytix plc | Chief Financial Officer | Ordinary Shares | 1.81M | $451K | $0.25 | Jul 1, 2023 | Direct |
| Renalytix plc | Chief Financial Officer | Employee Stock Option (right to buy) | 575K | Jul 6, 2023 | Direct | ||
| bluebird bio, Inc. | Chief Financial Officer | Stock Options (Right to buy) | 300K | Jul 1, 2024 | Direct | ||
| Star Mountain Credit Opportunities Fund, LP | Director | No securities are beneficially owned | 0 | May 13, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BLUE | bluebird bio, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Chief Financial Officer |
| BLUE | bluebird bio, Inc. | Jun 10, 2024 | 0 | $0 | 3 | Jun 13, 2024 | Chief Financial Officer |
| RNLX | Renalytix plc | Jul 6, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Chief Financial Officer |
| RNLX | Renalytix plc | Jul 1, 2023 | 0 | $0 | 3 | Jul 3, 2023 | Chief Financial Officer |
| NONE | Star Mountain Credit Opportunities Fund, LP | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | Director |